Operating Lease, Right-of-Use Asset of Context Therapeutics Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Context Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Context Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $138,622, a 43% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Context Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $138,622 -$105,513 -43% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $166,079 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $192,804 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $218,816 +$218,816 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $244,135 +$244,135 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q4 2023 $0 -$51,967 -100% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $0 -$73,752 -100% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $7,522 -$87,729 -92% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $29,892 -$86,575 -74% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $51,967 +$51,967 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $73,752 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $95,251 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $116,467 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 22 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.